Naturally, this can have a trickle-down effect on pharma’s ability to make medicine more available and less expensive, without sacrificing margins. Optimizing for better drug design ...

Insilico Medicine("Insilico ... AI for the design of novel molecules in a peer-reviewed journal in 2016, which laid the foundation for the commercially available Pharma.AI platform spanning ...

Drug discovery companies such as Insilico Medicine are ... of humans, to design new molecules that have the potential to treat diseases. As an end-to-end AI platform, Pharma.AI can discover ...

--(BUSINESS WIRE)--Evelyn Wang, PhD has joined Circle Pharma as its Vice President of Translational Medicine and will lead ... structure-based rational design and synthetic chemistry.